GenSight Biologics S.A. carries a market capitalization of 30.99M, placing it among publicly traded companies globally.
| Market Cap | 30.99M |
| Enterprise Value | N/A |
GenSight Biologics S.A.'s stock has declined approximately -20.79167% over the past 52 weeks. The 50-day moving average sits at 0.19, while the 200-day moving average is 0.19.
| Beta (5Y) | N/A |
| 52-Week Price Change | -20.79167% |
| 50-Day Moving Average | 0.19 |
| 200-Day Moving Average | 0.19 |
| Average Volume (20 Days) | N/A |